View Item 

Show simple item record

Agonists of proteinase-activated receptor-2 affect transendothelial migration and apoptosis of human neutrophils
dc.contributor.authorShpacovitch, Victoria M.en_US
dc.contributor.authorSeeliger, Stephanen_US
dc.contributor.authorHuber-Lang, Markus S.en_US
dc.contributor.authorBalkow, Sandraen_US
dc.contributor.authorFeld, Michaen_US
dc.contributor.authorHollenberg, Morley D.en_US
dc.contributor.authorSarma, Vidya J.en_US
dc.contributor.authorWard, Peter A.en_US
dc.contributor.authorStrey, Ankeen_US
dc.contributor.authorGerke, Volkeren_US
dc.contributor.authorSommerhoff, Christian P.en_US
dc.contributor.authorVergnolle, Nathalieen_US
dc.contributor.authorSteinhoff, Martinen_US
dc.date.accessioned2010-06-01T20:44:05Z
dc.date.available2010-06-01T20:44:05Z
dc.date.issued2007-10en_US
dc.identifier.citationShpacovitch, Victoria M.; Seeliger, Stephan; Huber-Lang, Markus; Balkow, Sandra; Feld, Micha; Hollenberg, Morley D.; Sarma, Vidya J.; Ward, Peter A.; Strey, Anke; Gerke, Volker; Sommerhoff, Christian P.; Vergnolle, Nathalie; Steinhoff, Martin (2007). "Agonists of proteinase-activated receptor-2 affect transendothelial migration and apoptosis of human neutrophils." Experimental Dermatology 16(10): 799-806. <http://hdl.handle.net/2027.42/73837>en_US
dc.identifier.issn0906-6705en_US
dc.identifier.issn1600-0625en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/73837
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=17845211&dopt=citationen_US
dc.format.extent688905 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights2007 The Authors Journal compilation 2007 Blackwell Munksgaarden_US
dc.subject.otherInflammationen_US
dc.subject.otherInnate Immunityen_US
dc.subject.otherLeukocyteen_US
dc.subject.otherProteinase-activated Receptoren_US
dc.subject.otherSkinen_US
dc.titleAgonists of proteinase-activated receptor-2 affect transendothelial migration and apoptosis of human neutrophilsen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelDentistryen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Pathology, University of Michigan Medical School, Ann Arbor, MI, USAen_US
dc.contributor.affiliationotherDepartment of Dermatology, IZKF MÜnster, and Boltzmann Institute for Immunobiology of the Skin, University of MÜnster, Germanyen_US
dc.contributor.affiliationotherDepartment of Traumatology, University of Ulm, Ulm, Germanyen_US
dc.contributor.affiliationotherCanadian Institutes of Health Research Proteinases and Inflammation Network, Department of Pharmacology and Therapeutics, University of Calgary, Calgary, AB, Canadaen_US
dc.contributor.affiliationotherInstitute of Biochemistry, ZMBE, University of MÜnster, MÜnster, Germanyen_US
dc.contributor.affiliationotherDepartment of Clinical Chemistry and Clinical Biochemistry, University of MÜnchen, MÜnchen, Germanyen_US
dc.identifier.pmid17845211en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/73837/1/j.1600-0625.2007.00605.x.pdf
dc.identifier.doi10.1111/j.1600-0625.2007.00605.xen_US
dc.identifier.sourceExperimental Dermatologyen_US
dc.identifier.citedreferenceHollenberg M D, Compton S J. International Union of Pharmacology. XXVIII. Proteinase-activated receptors. Pharmacol Rev 2002: 54: 203 – 217.en_US
dc.identifier.citedreferenceSteinhoff M, Buddenkotte J, Shpacovitch V et al. Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response. Endocr Rev 2005: 26: 1 – 43.en_US
dc.identifier.citedreferenceMolino M, Barnathan E S, Numerof R et al. Interactions of mast cell tryptase with thrombin receptors and PAR-2. J Biol Chem 1997: 272: 4043 – 4049.en_US
dc.identifier.citedreferenceNystedt S, Emilsson K, Larsson A K, Strombeck B, Sundelin J. Molecular cloning and functional expression of the gene encoding the human proteinase-activated receptor 2. Eur J Biochem 1995: 232: 84 – 89.en_US
dc.identifier.citedreferenceLourbakos A, Chinni C, Thompson P et al. Cleavage and activation of proteinase-activated receptor-2 on human neutrophils by gingipain-R from Porphyromonas gingivalis. FEBS Lett 1998: 435: 45 – 48.en_US
dc.identifier.citedreferenceSun G, Stacey M A, Schmidt M, Mori L, Mattoli S. Interaction of mite allergens Der p3 and Der p9 with protease-activated receptor-2 expressed by lung epithelial cells. J Immunol 2001: 167: 1014 – 1021.en_US
dc.identifier.citedreferenceUehara A, Muramoto K, Takada H, Sugawara S. Neutrophil serine proteinases activate human nonepithelial cells to produce inflammatory cytokines through protease-activated receptor 2. J Immunol 2003: 170: 5690 – 5696.en_US
dc.identifier.citedreferenceSteinhoff M, Corvera C U, Thoma M S et al. Proteinase-activated receptor-2 in human skin: tissue distribution and activation of keratinocytes by mast cell tryptase. Exp Dermatol 1999: 8: 282 – 294.en_US
dc.identifier.citedreferenceMiike S, McWilliam A S, Kita H. Trypsin induces activation and inflammatory mediator release from human eosinophils through protease-activated receptor-2. J Immunol 2001: 167: 6615 – 6622.en_US
dc.identifier.citedreferenceColognato R, Slupsky J R, Jendrach M, Burysek L, Syrovets T, Simmet T. Differential expression and regulation of protease-activated receptors in human peripheral monocytes and monocyte-derived antigen-presenting cells. Blood 2003: 102: 2645 – 2652.en_US
dc.identifier.citedreferenceHowells G L, Macey M G, Chinni C et al. Proteinase-activated receptor-2: expression by human neutrophils. J Cell Sci 1997: 110: 881 – 887.en_US
dc.identifier.citedreferenceMoormann C, Artuc M, Pohl E et al. Functional characterization and expression analysis of the proteinase-activated receptor-2 in human cutaneous mast cells. J Invest Dermatol 2006: 126: 746 – 755.en_US
dc.identifier.citedreferenceMaurer M, Metz M. The status quo and quo vadis of mast cells. Exp Dermatol 2005: 14: 923 – 929.en_US
dc.identifier.citedreferenceStander S, Steinhoff M. Pathophysiology of pruritus in atopic dermatitis: an overview. Exp Dermatol 2002: 11: 12 – 24.en_US
dc.identifier.citedreferenceOssovskaya V S, Bunnett N W. Protease-activated receptors: contribution to physiology and disease. Physiol Rev 2004: 84: 579 – 621.en_US
dc.identifier.citedreferenceNoorbakhsh F, Tsutsui S, Vergnolle N et al. Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis. J Exp Med 2006: 203: 425 – 435.en_US
dc.identifier.citedreferenceSeeliger S, Derian C K, Vergnolle N et al. Proinflammatory role of proteinase-activated receptor-2 in humans and mice during cutaneous inflammation in vivo. FASEB J 2003: 17: 1871 – 1885.en_US
dc.identifier.citedreferenceSchmidlin F, Amadesi S, Dabbagh K et al. Protease-activated receptor 2 mediates eosinophil infiltration and hyperreactivity in allergic inflammation of the airway. J Immunol 2002: 169: 5315 – 5321.en_US
dc.identifier.citedreferenceFerrell W R, Lockhart J C, Kelso E B et al. Essential role for proteinase-activated receptor-2 in arthritis. J Clin Invest 2003: 111: 35 – 41.en_US
dc.identifier.citedreferenceFiorucci S, Mencarelli A, Palazzetti B et al. Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis. Proc Natl Acad Sci U S A 2001: 98: 13936 – 13941.en_US
dc.identifier.citedreferenceNamkung W, Han W, Luo X et al. Protease-activated receptor 2 exerts local protection and mediates some systemic complications in acute pancreatitis. Gastroenterology 2004: 126: 1844 – 1859.en_US
dc.identifier.citedreferenceRiedemann N C, Guo R F, Ward P A. The enigma of sepsis. J Clin Invest 2003: 112: 460 – 467.en_US
dc.identifier.citedreferenceMcGirt L Y, Beck L A. Innate immune defects in atopic dermatitis. J Allergy Clin Immunol 2006: 118: 202 – 208.en_US
dc.identifier.citedreferenceEllis T N, Beaman B L. Interferon-gamma activation of polymorphonuclear neutrophil function. Immunology 2004: 112: 2 – 12.en_US
dc.identifier.citedreferenceCassatella M A, Huber V, Calzetti F et al. Interferon-activated neutrophils store a TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) intracellular pool that is readily mobilizable following exposure to proinflammatory mediators. J Leukoc Biol 2006: 79: 123 – 132.en_US
dc.identifier.citedreferenceSchroder K, Hertzog P J, Ravasi T, Hume D A. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 2004: 75: 163 – 189.en_US
dc.identifier.citedreferenceSchiller M, Metze D, Luger T A, Grabbe S, Gunzer M. Immune response modifiers–mode of action. Exp Dermatol 2006: 15: 331 – 341.en_US
dc.identifier.citedreferenceVincent J L, Sun Q, Dubois M J. Clinical trials of immunomodulatory therapies in severe sepsis and septic shock. Clin Infect Dis 2002: 34: 1084 – 1093.en_US
dc.identifier.citedreferenceShpacovitch V M, Varga G, Strey A et al. Agonists of proteinase-activated receptor-2 modulate human neutrophil cytokine secretion, expression of cell adhesion molecules, and migration within 3-D collagen lattices. J Leukoc Biol 2004: 76: 388 – 398.en_US
dc.identifier.citedreferenceWitko-Sarsat V, Rieu P, Descamps-Latscha B, Lesavre P, Halbwachs-Mecarelli L. Neutrophils: molecules, functions and pathophysiological aspects. Lab Invest 2000: 80: 617 – 653.en_US
dc.identifier.citedreferenceEdwards S. Biochemistry and Physiology of the Neutrophil. New York: Cambridge University Press, 1994.en_US
dc.identifier.citedreferenceShpacovitch V M, Brzoska T, Buddenkotte J et al. Agonists of proteinase-activated receptor 2 induce cytokine release and activation of nuclear transcription factor kappaB in human dermal microvascular endothelial cells. J Invest Dermatol 2002: 118: 380 – 385.en_US
dc.identifier.citedreferenceVergnolle N, Macnaughton W K, Al-Ani B, Saifeddine M, Wallace J L, Hollenberg M D. Proteinase-activated receptor 2 (PAR2)-activating peptides: identification of a receptor distinct from PAR2 that regulates intestinal transport. Proc Natl Acad Sci U S A 1998: 95: 7766 – 7771.en_US
dc.identifier.citedreferenceBone R C, Balk R A, Cerra F B et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992: 101: 1644 – 1655.en_US
dc.identifier.citedreferenceFeige U, Overwien B, Sorg C. Purification of human blood monocytes by hypotonic density gradient centrifugation in Percoll. J Immunol Methods 1982: 54: 309 – 315.en_US
dc.identifier.citedreferenceRohnelt R K, Hoch G, Reiss Y, Engelhardt B. Immunosurveillance modelled in vitro: naive and memory T cells spontaneously migrate across unstimulated microvascular endothelium. Int Immunol 1997: 9: 435 – 450.en_US
dc.identifier.citedreferenceHomburg C H, de Haas M, von dem Borne A E, Verhoeven A J, Reutelingsperger C P, Roos D. Human neutrophils lose their surface Fc gamma RIII and acquire Annexin V binding sites during apoptosis in vitro. Blood 1995: 85: 532 – 540.en_US
dc.identifier.citedreferenceColotta F, Re F, Polentarutti N, Sozzani S, Mantovani A. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 1992: 80: 2012 – 2020.en_US
dc.identifier.citedreferenceNystedt S, Ramakrishnan V, Sundelin J. The proteinase-activated receptor 2 is induced by inflammatory mediators in human endothelial cells. Comparison with the thrombin receptor. J Biol Chem 1996: 271: 14910 – 14915.en_US
dc.identifier.citedreferenceMuhl H, Pfeilschifter J. Anti-inflammatory properties of pro-inflammatory interferon-gamma. Int Immunopharmacol 2003: 3: 1247 – 1255.en_US
dc.identifier.citedreferenceCamerer E, Huang W, Coughlin S R. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc Natl Acad Sci U S A 2000: 97: 5255 – 5260.en_US
dc.identifier.citedreferenceCamerer E, Kataoka H, Kahn M, Lease K, Coughlin S R. Genetic evidence that protease-activated receptors mediate factor Xa signaling in endothelial cells. J Biol Chem 2002: 277: 16081 – 16087.en_US
dc.identifier.citedreferenceJin E, Fujiwara M, Pan X et al. Protease-activated receptor (PAR)-1 and PAR-2 participate in the cell growth of alveolar capillary endothelium in primary lung adenocarcinomas. Cancer 2003: 97: 703 – 713.en_US
dc.identifier.citedreferencede Haas M, Vossebeld P J, von dem Borne A E, Roos D. Fc gamma receptors of phagocytes. J Lab Clin Med 1995: 126: 330 – 341.en_US
dc.identifier.citedreferenceWagner J G, Roth R A. Neutrophil migration mechanisms, with an emphasis on the pulmonary vasculature. Pharmacol Rev 2000: 52: 349 – 374.en_US
dc.identifier.citedreferenceVarani J, Ward P A. Mechanisms of neutrophil-dependent and neutrophil-independent endothelial cell injury. Biol Signals 1994: 3: 1 – 14.en_US
dc.identifier.citedreferenceLentsch A B, Ward P A. Regulation of inflammatory vascular damage. J Pathol 2000: 190: 343 – 348.en_US
dc.identifier.citedreferenceSavill J. Apoptosis in resolution of inflammation. J Leukoc Biol 1997: 61: 375 – 380.en_US
dc.identifier.citedreferenceMcKenzie S E, Schreiber A D. Fc gamma receptors in phagocytes. Curr Opin Hematol 1998: 5: 16 – 21.en_US
dc.identifier.citedreferenceGoulding N J, Knight S M, Godolphin J L, Guyre P M. Increase in neutrophil Fc gamma receptor I expression following interferon gamma treatment in rheumatoid arthritis. Ann Rheum Dis 1992: 51: 465 – 468.en_US
dc.identifier.citedreferenceDavis B H, Olsen S H, Ahmad E, Bigelow N C. Neutrophil CD64 is an improved indicator of infection or sepsis in emergency department patients. Arch Pathol Lab Med 2006: 130: 654 – 661.en_US
dc.identifier.citedreferenceSteinhoff M, Griffiths C M E, Church M K, Luger T A. Inflammation. In: Burns T, Breathnach S, Cox N, Griffiths C, eds. Rook’s Textbook of Dermatology, 7th edn. Oxford: Blackwell Publishing Ltd., 2004.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1600-0625.2007.00605.x.pdf
Size:
672.7KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.